Phase II Study of PD-1 Inhibitor With Sintilimab After Stereotactic Ablation Brachytherapy for Refractory Oligometastatic Non-Small Cell Lung Cancer
Latest Information Update: 08 Sep 2023
At a glance
- Drugs Sintilimab (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 28 Jul 2020 New trial record